Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-17

Clinical Trial Update: In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis

View source ↗

Summary

An update from a Shandong University trial suggests that in vivo molecular imaging can predict therapeutic response in patients with ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Shandong University | Conditions: Ulcerative Colitis | Status: UNKNOWN